Audio

Veeral Sheth, MD, is joined by the director of marketing of eSight to discuss the 5th generation eSight Go, a device to enhance central vision functions in patients with a variety of eye diseases.

Panelists discuss how accurately diagnosing iron deficiency, selecting appropriate treatments like oral or intravenous iron, educating patients, and collaborating with specialists are essential for effective management and improving outcomes in hematology practice.

Explore the urgent need for diabetes specialists and the American College of Diabetology's efforts to enhance care through education and certification.

Hosts sit down for a deep dive into The Diabetes Collective and what it's like operating a diabetes clinic in the modern healthcare landscape.

Leading experts discuss managing atopic dermatitis in skin of color in a live recording from the 2025 Revolutionizing Atopic Dermatitis Conference.

Discover how the CATALYST trial reveals mifepristone's potential to enhance glycemic control and weight loss in challenging type 2 diabetes cases.

Explore groundbreaking findings from the REDEFINE trials on CagriSema's impact on weight loss and diabetes management at ADA 2025.

Kevin Sayer joins the program to discuss the latest from Dexcom and preview where the business is headed in an evolving diabetes landscape.

This episode of Lungcast features a discussion on emerging research in lung cancer biomarkers and early detection.

Explore the ethical dilemmas of vaccine policy and public trust in health systems as experts discuss the impact of COVID-19 on immunization attitudes.

In this episode of The Gus Alva Perspective, Gus Alva sits down with Roger McIntyre to discuss his highly anticipated keynote address, titled "The Intersection of Metabolism and Mood”, from the upcoming 2025 Southern California Psychiatry Conference.

This June 17, 2025 SOCS News Update highlights creating strategic plans with mentors and mentees.

Jonathan Meyer, MD, previews his session on updates in tardive dyskinesia at the upcoming 2025 Southern California Psychiatry Conference.

In this special episode, cohosts preview the most anticipated data and explore clinical implications in diabetes and obesity.

In the second part of a 2-part episode, hosts Kimberly Brown and Nancy Reau break down 3 more notable abstracts from the 2025 EASL Congress.

A recap of 3 Kidney Compass podcast episodes recorded at ERA 2025, including summaries and preview clips.

A deep dive into several noteworthy IgAN studies presented during the ERA 2025 Congress.

Discover groundbreaking insights on the VISIONARY trial, IgA nephropathy treatment, and the future of kidney care with expert Vlado Perkovic, MBBS, PhD.

Hosts break down data from the CONFIDENCE trial on the safety and efficacy of finerenone plus empagliflozin in patients with T2D and CKD.

Alva and Meyer offer a glimpse into what attendees can expect in the schizophrenia portion of the Southern California Psychiatry Conference.

Brendon Neuen, MBBS, PhD, is joined by Rajiv Agarwal, MD, MS to explore the concept of simultaneous initiation of SGLT2i and nsMRA in CKD and T2D.

Hosts discuss a consensus repot from the ADA focused on screening and early interview of MASLD in people with diabetes.

Hosts breakdown diabetes technology updates from May 2025 and Breakthrough T1D's push for improved screening.

The May 30, 2025 SOCS News Update highlights cosmetic concerns among patients with skin of color.

Gerard Criner, MD, spells out GOLD improvements, from interventions like smoking cessation and pulmonary rehabilitation to the heightened importance of spirometry for diagnosis.

In this episode, hosts explore technosphere inhaled insulin (Afrezza) in comparison to standard diabetes therapies in the INHALE-3 trial.

Amy Spizuoco, DO, joins the show to discuss her journey as a key opinion leader in dermatology.

Hosts break down their biggest takeaways and detail their favorite sessions from the AACE 2025 annual meeting.